Epinephrine 0.3 MG auto-inject 2S
Ended Awarded Last action
- Contract number
- SPE2D326F1662
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $5,053
Award facts
- Contract value 100% obligated
- $5,053.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $5,053.25 for epinephrine 0.3 mg auto-injector supplies on November 26, 2025. This firm fixed-price delivery order was issued without a set-aside designation by the Defense Logistics Agency's Medical Supply Chain division, with an ultimate completion date of November 28, 2025. The award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion federal acquisition strategy designed to provide comprehensive pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide.
The Pharmaceutical Prime Vendor Global Program Generation V represents a major modernization of the DoD's pharmaceutical supply chain, establishing multiple regional prime vendor contractors to deliver branded and generic prescription medications, biologics, vaccines, and medical consumables to military medical facilities globally. DMS Pharmaceutical Group's selection as a prime vendor contractor under this initiative, combined with its demonstrated performance on numerous delivery orders spanning oncology treatments, immunosuppressants, emergency medications, and routine pharmaceuticals, positions the company as a critical supplier within the federal military medical system. The company's established track record and comprehensive product portfolio demonstrate its capability to fulfill the specialized pharmaceutical requirements necessary to support DoD healthcare operations across multiple therapeutic categories.
Quick answers
Who was awarded contract SPE2D326F1662?
SPE2D326F1662 was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on November 26, 2025.
How much is contract SPE2D326F1662 worth?
The government has obligated $5,053 on SPE2D326F1662.
Is contract SPE2D326F1662 an order under another contract?
Yes. SPE2D326F1662 is a delivery order under SPE2D021DA002, an indefinite delivery contract.
Was contract SPE2D326F1662 competed?
The extent of competition for SPE2D326F1662 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award